Reply to Achieng and Riedel

Hanh Thi Pham^{1

2}, Mark E Goring^{1

3}, Thibault Mesplède^{1

2

3

4}

Affiliations

¹ McGill AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
² Department of Microbiology and Immunology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
³ Division of Experimental Medicine, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
⁴ Division of Infectious Diseases, Jewish General Hospital, Faculty of Medicine, McGill University, Montréal, Québec, Canada.

Comment

Hanh Thi Pham et al. J Infect Dis. 2019.

. 2019 Jan 1;219(1):167-169.

doi: 10.1093/infdis/jiy437.

Hanh Thi Pham^{1

2}, Mark E Goring^{1

3}, Thibault Mesplède^{1

2

3

4}

¹ McGill AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
² Department of Microbiology and Immunology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
³ Division of Experimental Medicine, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
⁴ Division of Infectious Diseases, Jewish General Hospital, Faculty of Medicine, McGill University, Montréal, Québec, Canada.

No abstract available

Comment on

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors.
Pham HT, Labrie L, Wijting IEA, Hassounah S, Lok KY, Portna I, Goring ME, Han Y, Lungu C, van der Ende ME, Brenner BG, Boucher CA, Rijnders BJA, van Kampen JJA, Mesplède T, Wainberg MA. Pham HT, et al. J Infect Dis. 2018 Jul 24;218(5):698-706. doi: 10.1093/infdis/jiy175. J Infect Dis. 2018. PMID: 29617824 Free PMC article.
Dolutegravir Resistance and Failure in a Kenyan Patient.
Achieng L, Riedel DJ. Achieng L, et al. J Infect Dis. 2019 Jan 1;219(1):165-167. doi: 10.1093/infdis/jiy436. J Infect Dis. 2019. PMID: 30165703 No abstract available.